Celyad to Present Updates On CYAD-01 at the American Association for Cancer Research (AACR) Annual Meeting – Business Wire (press release)
|
Celyad to Present Updates On CYAD-01 at the American Association for Cancer Research (AACR) Annual Meeting
Business Wire (press release) Celyad (Paris:CYAD) (Brussels:CYAD) (Euronext Brussels and Paris, and NASDAQ: CYAD) a clinical-stage biopharmaceutical company focused on the development of CART-cell therapies, today announced that the company will present updates on its ongoing Phase … |
